Ampicillin-insensitive Haemophilus influenzae type B causing acute epiglottitis.

D Hansman

doi:10.1016/s0140-6736(79)91992-5

Home/Archive/PubMed

PubMed · 87819

Ampicillin-insensitive Haemophilus influenzae type B causing acute epiglottitis.

D Hansman

View original source ↗Export metadata ↓

Abstract

The source did not provide an abstract. Follow the original record for more information.

Explore related subjects

Ampicillin Child, Preschool Epiglottis Female Haemophilus Infections Haemophilus influenzae Humans Laryngitis Penicillin Resistance Case Reports Letter

Keep this discovery

Explore connections, maps & timelines

BibTeX RIS

D Hansman. 1979-06-23. Ampicillin-insensitive Haemophilus influenzae type B causing acute epiglottitis.. https://doi.org/10.1016/s0140-6736(79)91992-5

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed1979

Qualitative detection of penicillinase produced by yeast strains carrying chimeric yeast-coli plasmids.

Explore the source record for details and available documents.

Ampicillin↗

PubMed1979

[Ampicillin in high doses as standard treatment of purulent meningitis and meningococcal sepsis in children over 2 months of age. Report of patient material].

Explore the source record for details and available documents.

Ampicillin↗

PubMed1979

[Minimal effective dose of bacampicillin in urinary tract infections (author's transl)].

66 patients from a nephrological out-patient clinic in whom an ampicillin-sensitive pathogen had been demonstrated after suprapubic puncture, were divided into 3 randomised groups. The first group received 10, the second 20 and the third 30 tablets of 800 mg bacampicillin each. Tablets were given t.i.d. Due to randomising comparable groups were formed. When different criteria were used for assessment of success no advantages of long-term or disadvantages of short-term treatment were found. 10 tablets (possibly even less) are thus the minimal inhibitory dosage for the disease. Present experience suggests a short treatment with follow-up controls at short intervals and then a long-term reinfection prophylaxis.

Ampicillin↗